UK earnings, trading statements calendar - next 7 days
15th Mar 2024 13:08
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - SkinBioTherapeutics PLC on Tuesday said its newly acquired Dermatonics will launch Pheet and Dermatonics Once Heel balm in Asia, the Middle East and Africa. Read More
SkinBioTherapeutics PLC - Newcastle, England-based life science company focused on skin health - Provides a trading update for the recently acquired Dermatonics Ltd, a Cambridgeshire-based manufacturer of skincare products. In January, SkinBio completed its acquisition of Dermatonics for an initial payment of GBP1.7 million, alongside a GBP1.3 million earn-out over three years. Dermatonics's revenue was GBP1.9 million for the year ended January 31, up 2.2% from GBP1.8 million a year prior. Earnings before interest, tax, depreciation and amortisation were GBP422,000 for the 12 months, up 77% from GBP230,000 adjusted Ebitda last year. Adjustments were a GBP150,000 stock write-off and GBP123,000 bad debt in financial 2023. As of January 31, Dermatonics had a cash balance of GBP149,000, down from GBP213,000. Read More
SkinBioTherapeutics PLC - Newcastle, England-based life science company focused on skin health - Completes the the acquisition of Dermatonics Ltd. On Thursday, it agreed to buy Dermatonics for GBP1.7 million initially, plus up to a GBP1.3 million earn-out over three years. St Ives, Cambridgeshire-based Dermatonics makes topical and dermatological products for skincare and woundcare, using natural ingredients wherever possible. It has annual earnings of GBP230,000 on GBP1.8 million in revenue. Read More
SkinBioTherapeutics PLC - Newcastle, England-based life science company focused on skin health - Agrees to acquire Dermatonics Ltd for GBP1.7 million initially, plus up to a GBP1.3 million earn-out over three years. St Ives, Cambridgeshire-based Dermatonics makes topical and dermatological products for skincare and woundcare, using natural ingredients wherever possible. It has annual earnings of GBP230,000 on GBP1.8 million in revenue. SkinBioTherapeutics says the acquisition will be financed with a GBP1.6 million drawdown from a new GBP5.0 million convertible bond issue. Read More
(Alliance News) - SkinBioTherapeutics PLC on Friday said it expects to complete an acquisition early in 2024, missing its year-end target. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
SkinBioTherapeutics PLC - Newcastle, England-based life science company focused on skin health - Raises GBP3.0 million through placing of 15.9 million shares at 19 pence each. Says placing was completed through an accelerated bookbuild and was "materially oversubscribed". Placing price represents a 9.5% discount to SkinBio's closing middle market price of 21p per share on November 15, the day before it launched the placing. Company says the placing shares will be admitted to AIM on Wednesday and will represent around 9.2% of its total issued share capital. Read More
(Alliance News) - (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - OptiBiotix Health PLC on Wednesday said sales from existing partners have improved in recent months, and that its move to focus on US and Asian markets is progressing well. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
SkinBioTherapeutics PLC - Newcastle-based life science company focused on skin health - Extends its collaboration contract with Sederma SAS, the cosmetics arm of Croda International PLC, for another 12 months. Says the extension is so Sederma can complete and assess further studies on SkinBiotix technology to look at "previously unseen beneficial properties", which could "significantly enhance commercial opportunities". Sederma will cover any costs of SkinBioTherapeutics concerning the supply of SkinBiotix for the studies."We are confident that this can lead to a wider commercialisation of our SkinbiotixTM technology into new products, which can make a great difference to consumers with a wide array of skincare needs," says CEO Stuart Ashman. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday. Read More
(Alliance News) - SkinBioTherapeutics PLC on Friday said it has received approval from regulators to sell AxisBiotix-Ps, a food supplement designed to treat symptoms of psoriasis, to consumers in France. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More